ALEXANDRIA, Va., March 17 -- United States Patent no. 12,577,306, issued on March 17, was assigned to Merus B.V. (Utrecht, Netherlands).
"Bispecific anti PD1-anti TIM3 antibodies" was invented by Cecilia Anna Wilhelmina Geuijen (Utrecht, Netherlands), Rinse Klooster (Utrecht, Netherlands), Cornelis Adriaan De Kruif (Utrecht, Netherlands), Paulus Johannes Tacken (Utrecht, Netherlands), Mark Throsby (Utrecht, Netherlands) and Ton Logtenberg (Utrecht, Netherlands).
According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provide means and methods for interfering with Programmed Cell Death 1 protein (PD-1) and T-cell immunoglobulin and mucin-domain containing-3 (TIM-3) mediated inhibition in a PD-1 and/or TIM...